Figure 3.
Anti-angiogenic and anti-metastatic actions of galangin by inhibiting p-Akt, p-70S6K, HIF-1, VEGF/R and Erk1/2, c-Fos, c-Jun, NF-κB and AP-1 pathways respectively. (A color version of this figure is available in the online journal.)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.